An attempt to explain the origin of the vivid red color in precious pink and red corals was undertaken. Raman and IR spectroscopies were applied to characterize white, pink and red corals. The position of the Raman signal near 1500 cm −1 of some corals and pearls was associated by several authors with the presence of the mixture of all-trans-polyenic pigments, containing 6-16 conjugated C C bonds or β-carotenoids. This hypothesis was examined theoretically by performing extensive B3LYP-DFT calculations of vibrational spectra of the model polyenic compounds. The B3LYP/6-311++G * * predicted positions of the dominating Raman mode depend on the number of C C units (Cn parameter) and can be accurately predicted for larger systems from a simple nonlinear fit. The DFT-predicted Raman activities of these modes are extremely sensitive to Cn, and sharply increase with the number of double bonds. This implies a presence of only -two to three polyenes differing slightly in the number of C C units as the source of color in pink and red corals.

It is known that palladium‐based catalysts are initially very active in direct formic acid oxidation but they suffer from fast deactivation caused by a strongly adsorbed CO intermediate. Reactivation of the catalysts involving application of anodic potential may cause palladium dissolution. The aim of the present study is to increase the stability and performance of palladium‐based catalysts in direct formic acid fuel cells (DFAFCs). Preparation and characterization of palladium/multiwalled carbon nanotubes (Pd/MWCNTs) and towards formic acid oxidation via different treatments are described. The catalysts were characterized by thermogravimetric analysis (TGA), X‐ray diffraction (XRD), transmission electron microscopy (TEM) and cyclic voltammetry (CV). It was shown that the Pd and Pd–Au MWCNTs supported catalysts after reduction in H2–Ar at 200 °C (R200 treatment) were highly active in formic acid electro‐oxidation, whereas the catalysts after heating in argon at 250 °C (C250 treatment) were inactive. The catalysts after hydrogen treatment have smaller metal particles and better contact with MWCNTs support. CV, simulating reactivation of the catalysts, showed that the Pd catalyst suffers from severe Pd dissolution, whereas for the Pd–Au selective leaching of Pd is considerably slower.

As the COVID-19 (Coronavirus disease 19) pandemic spreads worldwide, the massive numbers of COVID-19 patients have created a considerable healthcare burden for every country. The clinical spectrum of SARS-CoV-2 infection is broad, ranging from asymptomatic to mild, moderate, severe, and critical. Most COVID-19 patients present with no or mild symptoms, but nearly one-fifth of all patients develop severe or life-threatening complications. In addition to localized respiratory manifestations, severe COVID-19 cases also show extra-pulmonary complications or induce multiorgan failure. Identifying, triaging, and treating patients at risk early is essential and urgent. This article reviews the potential prognostic value of various biomarkers at different clinical spectrum stages of COVID-19 infection and includes information on fundamental prognostic mechanisms as well as potential clinical implications. Biomarkers are measurable biochemical substances used to recognize and indicate disease severity or response to therapeutic interventions. The information they provide is objective and suitable for delivering healthcare providers with a means of stratifying disease state in COVID-19 patients. This, in turn, can be used to help select and guide intervention efforts as well as gauge the efficacy of therapeutic approaches. Here, we review a number of potential biomarkers that may be used to guide treatment, monitor treatment efficacy, and form individualized therapeutic guidance based on patient response. Implementation of the COVID-19 biomarkers discussed here may lead to significantly improved quality of care and patient outcomes for those infected with SARS-CoV-2 worldwide.